An inexpensive epilepsy drug can “switch off” autism, according to a new peer-reviewed study published Tuesday in the journal Molecular Psychiatry.
Led by Dr. Moritz Mall from the Hector Institute for Translational Brain Research in Germany, researchers in the study found that the drug lamotrigine, which is sold under the brand name Lamictal, among others, was able to curb behavioral issues associated with autism spectrum disorder (ASD).
